Role of CD8+ lymphocytes in host defense against Pneumocystis carinii in mice

Journal of Laboratory and Clinical Medicine

Volumn 128, Issue 5, 1996, Pages 477-487

  Beck, James M ^a   Newbury, Robert L ^b   Palmer, Brent E ^b   Warnock, Martha L ^b   Byrd, Patricia K ^b   Kaltreider, H Benfer ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030282653     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90044-X     Document Type: Article

References (29)

1. Newbury RL, Beck JM. Immunology of the lung in HIV-infected individuals. Semin Respir Med 1995;16:161-72.
2. Phair J, Muñoz A, Detels R, et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med 1990;322:161-5.
3. Shellito J, Suzara W, Blumenfeld W, Beck JM, Steger HJ, Ermak TH. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest 1990;85:1686-93.
4. Beck JM, Warnock ML, Curtis JL, et al. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am J Respir Cell Mol Biol 1991;5: 186-97.
5. Harmsen AG, Stankiewicz M. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med 1990;172:937-45.
6. Murray HW, Hillman JK, Rubin BY, et al. Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production. N Engl J Med 1985;313:1504-10.
7. Autran B, Plata F, Guillon JM, Joly P, Mayaud C, Debré P. HIV-specific cytotoxic T lymphocytes directed against alveolar macrophages in HIV-infected patients. Res Virol 1990; 141:131-6.
8. Lane HC. Immunoregulation, immune defects, and clinical strategies in HIV infection. Mt Sinai J Med 1992;59:244-52.
9. Suzuki Y, Remington JS. The effect of anti-IFN-γ antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. J Immunol 1990;144:1954-6.
10. Roths JB, Sidman CL. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. J Clin Invest 1992;90:673-8.
11. Dialynas DP, Wilde DB, Marrack P, et al. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class IIMHC antigen reactivity. Immunol Rev 1983;74:29-56.
12. Sarmiento M, Glasebrook AL, Fitch FW. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol 1980;125:2665-72.
13. Mishell BB, Shiigi SM. Selected methods in cellular immunology. San Francisco: WH Freeman & Co., 1980.
14. Goding JW. Conjugation of antibodies with fluorochromes: modifications to the standard methods. J Immunol Methods 1976;13:215-26.
15. Ledbetter JA, Herzenberg LA. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979;47:63-90.
16. Coffman RL. Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol Rev 1982;69:5-23.
17. Walzer PD, Powell RD Jr, Yoneda K, Rutledge ME, Milder JE. Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia. Infect Immun 1980;27:928-37.
18. Saltini C, Hance AJ, Ferrans VJ, Basset F, Bitterman PB, Crystal RG. Accurate quantification of cells recovered by bronchoalveolar lavage. Am Rev Respir Dis 1984;130:650-8.
19. Curtis JL, Kaltreider HB. Characterization of bronchoalveolar lymphocytes during a specific antibody-forming cell response in the lungs of mice. Am Rev Respir Dis 1989;139:393-400.
20. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall, 1984.
21. Ishimine T, Kawakami K, Nakamoto A, Saito A. Analysis of cellular response and gamma interferon synthesis in bronchoalveolar lavage fluid and lung homogenate of mice infected with Pneumocystis carinii. Microbiol Immunol 1995;39: 49-58.
22. Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukocyte Biol 1994;55:35-42.
23. Pomeroy C, Miller L, McFarling L, Kennedy C, Filice GA. Phenotypes, proliferative responses and suppressor function of lung lymphocytes during Toxoplasma gondii pneumonia in mice. J Infect Dis 1991;164:1227-32.
24. Beck JM, Liggitt HD, Brunette EN, Fuchs HJ, Shellito JE, Debs RJ. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect Immun 1991;59:3859-62.
25. Theus SA, Andrews RP, Steele P, Walzer PD. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat. J Clin Invest 1995;95:2587-93.
26. Herrod HG, Valenski WR, Woods DR, Pifer LL. The in vitro response of human lymphocytes to Pneumocystis carinii antigen. J Immunol 1981;126:59-61.
27. Forte M, Maartens G, Campbell F, et al. T-lymphocyte responses to Pneumocystis carinii in healthy and HIV-positive individuals. Journal of Acquired Immune Deficiency Syndromes 1992;5:409-16.
28. Theus SA, Linke MJ, Andrews RP, Walzer PD. Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii. Infect Immun 1993;61:4703-9.
29. Fisher DJ, Gigliotti G, Zauderer M, Harmsen AG. Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp120) after immunization and natural infection. Infect Immun 1991;59:3372-6.